IceCure Medical Ltd. - Ordinary Shares (ICCM)
ICCM moved a median of -1.17% 30 minutes after news, and -1.91% by the close. How ICCM actually reacts to news — the realized, point-in-time move the market made, measured across 331 labeled events over the last three years with zero look-ahead.
ICCM’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.50% | 33% | 328 |
| 30-min | -1.17% | 34% | 330 |
| 60-min | -1.22% | 35% | 330 |
| to close | -1.91% | 34% | 330 |
| Middle 50% of ICCM reactions | -2.96% to +0.54% |
|---|---|
| Median reaction (30-min) | -1.17% |
| Measured reactions | 331 |
Half of all IceCure Medical Ltd. - Ordinary Shares news events land between -2.96% and +0.54% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ICCM moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ICCM's baseline. Nothing else.
Recent ICCM events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 6-K IceCure Medical Ltd. For: Oct 13 | SEC filing · Form 6-K | SEC EDGAR | -0.86% | -0.90% | |
| IceCure Highlights Clinical Data and Strong Physician Engagement for ProSense® Breast Cancer Cryoablation at EUSOBI 2026 | Press release | PR Newswire | -0.86% | -0.90% | |
| IceCure Expands ProSense® ChoICE Study for Low-Risk Breast Cancer adding Legacy Health in Portland, OR as U.S. Clinical Site | Press release | PR Newswire | +0.67% | -14.77% | |
| Form 6-K IceCure Medical Ltd. For: Oct 05 | SEC filing · Form 6-K | SEC EDGAR | -1.26% | -3.15% | |
| Form 6-K IceCure Medical Ltd. For: Sep 28 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | -3.64% | |
| Form 6-K IceCure Medical Ltd. For: Sep 10 | SEC filing · Form 6-K | SEC EDGAR | +0.00% | +2.88% | |
| IceCure Medical Receives Regulatory Approval to Market ProSense® in China | Press release | PR Newswire | +0.00% | +2.88% | |
| Form 6-K IceCure Medical Ltd. For: Aug 24 | SEC filing · Form 6-K | SEC EDGAR | -3.36% | -4.62% | |
| IceCure Signs Exclusive Distribution Agreement for ProSense® Cryoablation Systems in the Netherlands | Press release | PR Newswire | -3.36% | -4.62% | |
| West Cancer Center Receives IRB Approval to Commence IceCure's ChoICE Study for Breast Cancer Cryoablation | Press release | PR Newswire | +3.17% | -2.78% | |
| Form EFFECT IceCure Medical Ltd. | SEC filing · Form EFFECT | SEC EDGAR | +3.32% | -7.01% | |
| Form 6-K IceCure Medical Ltd. For: Aug 14 | SEC filing · Form 6-K | SEC EDGAR | -0.33% | -7.84% | |
| Form S-8 IceCure Medical Ltd. | SEC filing · Form S-8 | SEC EDGAR | -0.33% | -7.84% | |
| Form POS AM IceCure Medical Ltd. | SEC filing · Form POS | SEC EDGAR | +1.56% | -0.66% | |
| IceCure Highlights Two New Peer-Reviewed Publications Supporting Cryoablation in Breast Cancer Treatment De-Escalation | Press release | PR Newswire | +0.64% | -3.85% | |
| Form 6-K IceCure Medical Ltd. For: Jun 30 | SEC filing · Form 6-K | SEC EDGAR | +2.33% | +3.50% | |
| IceCure Reports its Financial Results for the First Half of 2026 with 45% Revenue Growth Year-Over-Year | Press release | PR Newswire | +2.33% | +3.50% | |
| Form 6-K IceCure Medical Ltd. For: Aug 11 | SEC filing · Form 6-K | SEC EDGAR | +2.33% | +3.50% | |
| Form 6-K IceCure Medical Ltd. For: Aug 06 | SEC filing · Form 6-K | SEC EDGAR | -1.27% | -1.91% | |
| IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment | Press release | PR Newswire | -0.57% | -11.49% | |
| IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 | Press release | PR Newswire | +0.63% | +1.58% | |
| IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense® | Press release | PR Newswire | +0.68% | -1.71% | |
| IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site | Press release | PR Newswire | +0.33% | -4.64% | |
| IceCure Expands U.S. Commercial Team to Meet Surging Demand for ProSense® Cryoablation | Press release | PR Newswire | +2.71% | +2.56% | |
| Form EFFECT IceCure Medical Ltd. | SEC filing · Form EFFECT | SEC EDGAR | -8.64% | -9.43% | |
| IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer | Press release | PR Newswire | -8.64% | -9.43% | |
| Form 6-K IceCure Medical Ltd. For: Jul 02 | SEC filing · Form 6-K | SEC EDGAR | -8.64% | -9.43% | |
| Form 6-K IceCure Medical Ltd. For: Jun 26 | SEC filing · Form 6-K | SEC EDGAR | +2.87% | -11.30% | |
| Form 6-K IceCure Medical Ltd. For: Jun 25 | SEC filing · Form 6-K | SEC EDGAR | -11.91% | -16.43% | |
| Form D IceCure Medical Ltd. | SEC filing · Form D | SEC EDGAR | -6.40% | -7.02% | |
| Form F-3 IceCure Medical Ltd. | SEC filing · Form F-3 | SEC EDGAR | -6.40% | -7.02% | |
| IceCure Regains Compliance with Nasdaq Minimum Bid Price Requirement | Press release | PR Newswire | -11.91% | -16.43% | |
| IceCure Highlights New Peer-Reviewed Journal Article in Leading Surgery Journal, Demonstrating Cryoablation's Advantages Over Radiofrequency Ablation for Early-Stage Breast Cancer | Press release | PR Newswire | -6.68% | -6.28% | |
| Form 6-K IceCure Medical Ltd. For: Jun 18 | SEC filing · Form 6-K | SEC EDGAR | -3.25% | -15.77% | |
| IceCure Announces Pricing of $5.5 Million Private Placement Priced At a Premium to the Market Price with a Single Healthcare Focused Institutional Investor | Press release | PR Newswire | -20.83% | -28.13% | |
| IceCure Reports 70% Growth in Active U.S. Commercial Install Base for Breast Cancer Cryoablation Following FDA Clearance | Press release | PR Newswire | +18.13% | +51.66% | |
| Form 6-K IceCure Medical Ltd. For: Jun 02 | SEC filing · Form 6-K | SEC EDGAR | -0.54% | -17.26% | |
| IceCure Medical Announces 1-for-30 Reverse Share Split to Support Nasdaq Compliance | Press release | PR Newswire | -0.54% | -17.26% | |
| Form 6-K IceCure Medical Ltd. For: May 19 | SEC filing · Form 6-K | SEC EDGAR | -1.38% | +1.74% | |
| IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked | Press release | PR Newswire | -1.38% | +1.74% | |
| Form 6-K IceCure Medical Ltd. For: May 13 | SEC filing · Form 6-K | SEC EDGAR | -1.19% | -0.82% | |
| IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement | Press release | PR Newswire | -1.19% | -0.82% | |
| Form 6-K IceCure Medical Ltd. For: May 12 | SEC filing · Form 6-K | SEC EDGAR | -0.52% | +4.35% | |
| IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America | Press release | PR Newswire | -0.52% | +4.35% | |
| Form 6-K IceCure Medical Ltd. For: May 11 | SEC filing · Form 6-K | SEC EDGAR | -0.52% | +4.35% | |
| Form 6-K IceCure Medical Ltd. For: May 06 | SEC filing · Form 6-K | SEC EDGAR | -2.17% | -6.37% | |
| IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026 | Press release | PR Newswire | +1.02% | -2.99% | |
| IceCure Showcases ProSense® Cryoablation at American Society of Breast Surgeons 2026 Annual Meeting as Commercial Momentum Accelerates in the U.S. Market | Press release | PR Newswire | +1.65% | -6.35% | |
| Form 6-K IceCure Medical Ltd. For: Apr 22 | SEC filing · Form 6-K | SEC EDGAR | -3.43% | -9.16% | |
| Form 6-K IceCure Medical Ltd. For: Apr 21 | SEC filing · Form 6-K | SEC EDGAR | +5.02% | -3.63% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ICCM section they belong to.
Where else ICCM is measured.
ICCM earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is IceCure Medical Ltd. - Ordinary Shares's median reaction calculated?
Every labeled ICCM news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 331 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 34% of ICCM's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ICCM's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.